References
Abrams DI, Kuno S, Wong R, Jeffords K, Nash M, et al. Oral dextran sulfate (UAOO1) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Annals of Internal Medicine 110: 183–188, 1989
Bach MC, Valenti AJ, Howell DA, Smith TJ. Odynophagia from aphthous ulcers of the pharynx and esophagus in the acquired immunodeficiency syndrome (AIDS). Annals of Internal Medicine 109: 338–339, 1988
Brettle RP, Jones GA, Bingham J, Spacey BEM, Weatherley B. Pharmacokinetics of zidovudine in IVDU related HIV infection. Fifth International Conference on AIDS, Montreal, Abstract no. W.B.O.3, p. 203, 1989
Brockmeyer NH, Mertins L, Goos M. Effect of zidovudine with phase I and II metabolism in the liver. Fifth International Conference on AIDS, Montreal. Abstract no. M.B.P.335, p. 277, 1989
Chander P, Soni A, Suri A, Bhagwat R, et al. Renal ultraslructural markers in AIDS-associated nephropathy. American Journal of Pathology 126: 513–526, 1987
Connolly GM, Shanson D, Hawkins DA, Webster JN, Gazzard BG. Non-cryptosporidial diarrhoea in human immunodeficiency virus (HIV) infected patients. Gut 30: 195–200, 1989
Friedman SL, Gastrointestinal symptoms in AIDS: diagnosis, evaluation, and treatment. AIDS Clinical Care 1(3): 17–20, 1989
Hagopian WA, Huseby JS. Pneumocystis hepatitis and choroiditis despite successful aerosolized pentamidine pulmonary prophylaxis. Chest 96: 949–951, 1989
Janoff EN, Smith PD. Perspectives on gastrointestinal infections in AIDS. Gastroenterology Clinics of North America 17: 451–463, 1988
Koda RT, Ko RJ, Antoniskis D, Shields M, Melancon H. Effect of acetaminophen (ACET) on the pharmacokinetics of zidovudine (AZT). Fifth International Conference on AIDS, Montreal. Abstract no. W.B.O.5, p. 203, 1989
Kornhauser DM, Petty BG, Hendrix CW, Woods AS, Nerhood LJ, et al. Probenecid and zidovudine metabolism. Lancet 2: 473–475, 1989
Lähdevirta J, Maury CPJ, Teppo A-M, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. American Journal of Medicine 85: 289–291, 1988
Lake-Bakaar G, Beidas S, El-Sakir R, Iyer S, Straus E. Impaired gastric acid secretion in AIDS. Abstract. Gastroenterology 92: 1488, 1987
Lorentsen KJ, Hendrix CW, Collins JM, Kornhauser DM, Petty BG. Dextran sulfate is poorly absorbed after oral administration. Annals of Internal Medicine 111: 561–566, 1989
Merigan TC, Skowron G, Bozzette SA, Richman D, Uttamchandani R, et al. Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. Annals of Internal Medicine 110: 189–194, 1989
Morse GD, Olson J, Portmore A, Taylor C, et al. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and asymptomatic human immunodeficiency virus (HIV) infection. Antiviral Research 11: 57–65, 1989
Nelson JA, Wiley CA, Reynolds-Kohler C, Reese CE, Margaretten W, et al. Human immunodeficiency virus detected in bowel epithelium for patients with gastrointestinal symptoms. Lancet 1: 259–262, 1988
NIAID. Important information on results of a controlled clinical trial of zidovudine treatment of asymptomatic HIV infection: a note to physicians. Division of AIDS, NIAID, NIH, August 31, 1989
Pardo Y, Aldana M, Colton RM, Fischl MA, et al. Glomerular lesions in the acquired immunodeficiency syndrome. Annals of Internal Medicine 101: 429–444, 1984
Rao TKS, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. New England Journal of Medicine 316: 1062–1068, 1987
Reddy MM, Sorrell SJ, Lange M, Grieco MH. Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations. Journal of Acquired Immune Deficiency Syndromes 1: 436–440, 1988
Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD. Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. Journal of the American Medical Association 255: 1887–1891, 1986
Rubio FR, Crews T, Garland WA, Fukuda EK. Quantification of dideoxycytidine in human plasma by gas chromatography/mass spectrometry. Biomedical and Environmental Mass Spectrometry 17: 399–404, 1988
Schneiderman DJ, Arenson DM, Cello JP, Margaretten W, Weber TE. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology 7: 925–930, 1987
Singh G, Renton KW, Stebbing N. Homogeneous interferon from E, coli depresses hepatic cytochrome P-450 and drug biotransformation. Biochemical and Biophysical Research Communications 106: 1256–1261, 1982
Szebeni J, Wahl SM, Popovic M, Wahl LM, Gartner S, et al. Dipyridamole potentiates the inhibition by 3′-azido-3′-deoxythymidine and other dideoxynucleosides of human immunodeficiency virus replication in monocyte-macrophages. Theoretical Immunology Section, National Cancer Institute, Bethesda, MD 20892. Proceedings of the National Academy of Sciences of the United States of America 86: 3842–3846, 1989
Vogt MW, Hartshorn KL, Furman PA, Chou TC, Fyfe JA, et al. Ribavirin antagonizes the effect of azidothymidine on HIV replication. Science 235: 1376–1379, 1987
West MA, Keller GA, Cerra FB, Simmons RL. Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infection and Immunity 49: 563–570, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Unadkat, J.D., Agosti, J.M. Problems in Pharmacokinetic Investigations in Patients with HIV Infection. Clin Pharmacokinet 19, 172–176 (1990). https://doi.org/10.2165/00003088-199019030-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-199019030-00002